Home » Topics » BioWorld Science

BioWorld Science
RSS

Daiichi Sankyo, Sanford Burnham Prebys patent AP-TNAP inhibitors

May 15, 2020

Phase II/III data support potential of rAAV2-ND4 gene therapy in patients with LHON

May 15, 2020

Researchers identify AMRC-835 for MBL-positive Gram-negative bacterial infections

May 15, 2020

Pharmacodynamic and safety data presented for emixustat

May 15, 2020

SHR-170008 immunotherapy demonstrates antitumor efficacy in vivo

May 15, 2020

Kaleido initiates developmental program of KB-109 in mild to moderate COVID-19

May 15, 2020

Krystal Biotech announces positive interim data from phase I/II study of KB-105

May 15, 2020

FDA approves IND application for SMP-100 as treatment of IBS

May 15, 2020

Abivax receives clearance to initiate phase IIb/III study of ABX-464 COVID-19 patients

May 15, 2020

Advaxis reports positive preliminary data from ongoing phase I/II study of ADXS-503 in NSCLC

May 15, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...